Literature DB >> 34449000

Effect of ketogenic diet for drug-resistant epilepsy on immunological cells.

May Fouad Nassar1, Yasmin Gamal Abdou El-Gendy2, Mohamed Tarif Hamza3, Marwa Nasser Mohamed4, Nesrine Radwan5.   

Abstract

BACKGROUND AND AIM OF THE WORK: Ketogenic diet (KD) is one of the treatments in drug-resistant epilepsy (DRE). The current study aimed at assessing the effect of KD-induced ketosis on different immunological cells since ketosis is reported to affect neutrophil function.
METHODOLOGY: We recruited 21 pediatric patients diagnosed with DRE assigned to start KD. Anthropometric measurements, complete blood picture with differential count, phagocytic function, lymphocyte subsets, and IgG estimation were estimated initially and after 6 months of KD.
RESULTS: There were no differences between the initial total leucocytic, neutrophil, and lymphocytic counts as well as the lymphocyte subsets, and the values after 6 months of KD. IgG values showed significant increase yet the values were still within the reference ranges. For the innate immune system, the phagocytic index was assessed and it showed a marked statistical reduction in patients after KD.
CONCLUSION: KD has no effect on neutrophil and lymphocytic counts as well as the number of adaptive and immune cells; nevertheless, it causes a reduction in phagocytic index in DRE. Accordingly, further detailed study for the full immunological profile and function is needed to ensure the safety of this therapeutic line and correlate it with the clinical history.
© 2021. Fondazione Società Italiana di Neurologia.

Entities:  

Keywords:  Epilepsy; Fungal infection; Ketogenic diet; Phagocytic function

Mesh:

Substances:

Year:  2021        PMID: 34449000     DOI: 10.1007/s10072-021-05574-8

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  5 in total

1.  Reduction in serum leptin and IGF-1 but preserved T-lymphocyte numbers and activation after a ketogenic diet in rheumatoid arthritis patients.

Authors:  D A Fraser; J Thoen; S Bondhus; M Haugen; J E Reseland; O Djøseland; O Førre; J Kjeldsen-Kragh
Journal:  Clin Exp Rheumatol       Date:  2000 Mar-Apr       Impact factor: 4.473

Review 2.  The current and emerging therapeutic approaches in drug-resistant epilepsy management.

Authors:  Amir Mehdizadeh; Mohammad Barzegar; Sohrab Negargar; Azita Yahyavi; Sina Raeisi
Journal:  Acta Neurol Belg       Date:  2019-03-13       Impact factor: 2.396

3.  Effectiveness of the ketogenic diet in a broad range of seizure types and EEG features for severe childhood epilepsies.

Authors:  S Beniczky; M Jose Miranda; J Alving; J Heber Povlsen; P Wolf
Journal:  Acta Neurol Scand       Date:  2009-11-26       Impact factor: 3.209

4.  A randomized controlled trial of the ketogenic diet in refractory childhood epilepsy.

Authors:  D A J E Lambrechts; R J A de Kinderen; J S H Vles; A J A de Louw; A P Aldenkamp; H J M Majoie
Journal:  Acta Neurol Scand       Date:  2016-03-29       Impact factor: 3.209

5.  Ketogenic diet experience at Ondokuz Mayıs University.

Authors:  Emine Tekin; Filiz Mıhçı Serdaroğlu; Şerife Şahin; Haydar Ali Taşdemir
Journal:  Neurol Sci       Date:  2020-10-26       Impact factor: 3.307

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.